Free Trial

Rigel Pharmaceuticals (RIGL) Earnings Date, Estimates & Call Transcripts

Rigel Pharmaceuticals logo
$20.12 +0.42 (+2.13%)
As of 05/20/2025 04:00 PM Eastern

Rigel Pharmaceuticals Earnings Summary

Rigel Pharmaceuticals announced Q1 2025 earnings on May 6, 2025, reporting an EPS of $0.63, which beat the consensus estimate of $0.14 by $0.49. Quarterly revenue was reported to be $53.33 million, above the consensus estimate of $43.87 million. With a trailing EPS of $2.07 and a P/E Ratio of 143.72, Rigel Pharmaceuticals' earnings are expected to grow 377.27% next year, from $0.22 to $1.05 per share.

Upcoming Q2
Earnings Date
Aug. 5After Market ClosesEstimated
Consensus EPS
(May. 6)
$0.14
Actual EPS
(May. 6)
$0.63 Beat By $0.49
Actual Revenue
(May. 6)
$53.33M

Q1 2025 Earnings Resources

RIGL Upcoming Earnings

Rigel Pharmaceuticals' next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules.

Get Rigel Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rigel Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RIGL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RIGL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Rigel Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20252-$0.07$0.10$0.02
Q2 20252$0.14$2.52$1.33
Q3 20252$0.08$0.38$0.23
Q4 20252$0.16$0.45$0.31

Rigel Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2025
(Estimated)
--------
5/6/2025Q1 2025$0.14$0.63+$0.49$0.63$43.87M$53.33M
3/4/2025Q4 2024$0.30$0.80+$0.50$0.80$57.59M$57.60M
11/7/2024Q3 2024$0.0080$0.70+$0.6920$0.70$40.69M$55.31M
8/6/2024Q2 2024-$0.37-$0.06+$0.31-$0.06$32.38M$36.84M
5/7/2024Q1 2024-$0.30-$0.50 -$0.20-$0.05$31.28M$29.53M
11/7/2023Q3 2023-$0.70-$0.30+$0.40-$0.03$27.83M$28.13M
8/1/2023Q2 2023-$0.80-$0.40+$0.40-$0.04$26.02M$26.89M

Rigel Pharmaceuticals Earnings - Frequently Asked Questions

Rigel Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on RIGL's earnings history.

Rigel Pharmaceuticals issued an update on its FY 2025 earnings guidance on Tuesday, May, 6th. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $197.8 million.

In the previous quarter, Rigel Pharmaceuticals (NASDAQ:RIGL) reported $0.63 earnings per share (EPS) to beat the analysts' consensus estimate of $0.14 by $0.49. Learn more on analysts' earnings estimate vs. RIGL's actual earnings.

The conference call for Rigel Pharmaceuticals's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Rigel Pharmaceuticals's latest earnings report can be read online.
Read Transcript

Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded annual revenue of $203.08 million.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded net income of -$25.09 million. RIGL has generated $2.07 earnings per share over the last four quarters.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a trailing price-to-earnings ratio of 143.72 and a forward price-to-earnings ratio of 91.45.

Rigel Pharmaceuticals's earnings are expected to grow from $0.22 per share to $1.05 per share in the next year, which is a 377.27% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:RIGL) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners